Bishal Gyawali: Pleased to Speak on the Cost of Convenience and De-escalation Trials at IGCS 2026
Bishal Gyawali/oncology.queensu.ca

Bishal Gyawali: Pleased to Speak on the Cost of Convenience and De-escalation Trials at IGCS 2026

Bishal Gyawali, Associate Professor at Queen’s University, shared on LinkedIn:

“I had the pleasure of speaking at the International Gynecological Cancer Society Annual Meeting 2026 in Montreal on Friday about the Cost of Convenience and De-escalation clinical trials in oncology.

Proud to promote the work of our fellows.”

Bishal Gyawali

Other articles about IGCS 2026 on OncoDaily.